If you take prescription drugs — and roughly 90 percent of Medicare beneficiaries do — a federal policy shift now moving through Washington could raise what you pay every month for that coverage. The Trump administration has moved to end or significantly restructure the enhanced subsidy payments that insurance companies have relied on to keep Medicare Part D premiums low and Medicare Advantage extra benefits generous. For millions of people on fixed incomes, this is not an abstract budget debate. It is a direct threat to the monthly cost of staying covered.
To understand what is at stake, you need to know how Part D is actually funded. Standalone prescription drug plans and Medicare Advantage plans with drug coverage are offered by private insurers, not the federal government directly. Washington pays those insurers a base subsidy to participate in the program, and in recent years it added enhanced payments tied to the Inflation Reduction Act — payments designed to help insurers absorb the cost of new consumer protections, including the landmark $2,000 annual out-of-pocket cap on drug spending that took effect in 2025. When the administration signals it will pull back those enhanced payments, insurers face a straightforward financial choice: absorb the loss, narrow the drugs they cover, or raise premiums. Based on how the Part D market has responded to payment pressure in the past, most analysts expect a combination of all three.
The Data Snapshot here is instructive. According to CMS.gov data, the average basic Medicare Part D premium in 2025 was approximately $46.50 per month nationally, though individual plan premiums ranged from under $10 to more than $100 depending on the plan and the state. Total Part D enrollment — including both standalone Prescription Drug Plans and Medicare Advantage Prescription Drug plans — exceeded 60 million people in 2025. CMS data also shows that in 2025, there were 766 standalone Part D plans available nationally, down from 1,429 a decade earlier, reflecting ongoing market consolidation. Even a modest premium increase of $15 to $25 per month across that enrollment base shifts hundreds of millions of dollars in annual costs from the federal government onto beneficiaries. For someone collecting $1,800 a month in Social Security, an extra $20 a month is not a rounding error — it is a grocery run.
The $2,000 out-of-pocket cap deserves special attention because there is real confusion about whether it survives this policy change. It does. The cap was written into law by the Inflation Reduction Act and cannot be eliminated by an administrative decision alone — it would require an act of Congress to repeal. That protection remains in place for 2026 and is genuinely significant for anyone taking cancer medications, biologics, or other specialty drugs that previously cost thousands of dollars per year out of pocket. What is not protected by law is the premium you pay to be enrolled in a plan that includes this protection. Insurers can and likely will adjust premiums upward to compensate for reduced federal payments, even as the cap itself stays intact.
Medicare Advantage enrollees face a parallel set of risks. Most MA plans bundle drug coverage into a single monthly premium, and those plans have also benefited from federal benchmark payments that allowed insurers to offer $0-premium plans loaded with extra benefits — dental, vision, hearing aids, gym memberships, over-the-counter allowances, and transportation to medical appointments. According to CMS.gov data, the average Medicare Advantage premium in 2025 was approximately $17 per month, but that figure conceals enormous variation: some plans charge nothing, others charge $80 or more. When federal payment rates tighten, the first things insurers typically cut are those supplemental benefits, followed by premium increases on plans that previously cost nothing. If you enrolled in a $0-premium MA plan specifically because of its dental or vision coverage, do not assume those benefits will be there in 2026 at the same price.
The single most important action you can take right now is to commit to actively reviewing your coverage during the Annual Enrollment Period, which runs from October 15 through December 7 every year. During AEP, you can switch from one Part D plan to another, move from Original Medicare to Medicare Advantage, switch between Medicare Advantage plans, or drop Medicare Advantage and return to Original Medicare — all without any health screening or medical underwriting. Whatever you choose during AEP takes effect January 1 of the following year. Every fall, insurers are required to mail you an Annual Notice of Change letter by September 30. That letter details every change to your plan for the coming year — premium increases, formulary changes, new prior authorization requirements, and benefit reductions. Read it carefully. If your premium is rising substantially or a medication you take is moving to a higher cost-sharing tier, that is your signal to shop.
The Medicare Plan Finder tool at Medicare.gov is the most reliable free resource for doing that comparison. You enter your specific medications, dosages, preferred pharmacy, and zip code, and the tool calculates your estimated total annual drug costs — premiums plus copays — across every plan available in your area. This distinction matters enormously: a plan with a $28 monthly premium might cost you $2,400 per year once you factor in copays on your specific drugs, while a plan with a $55 monthly premium might cost you only $1,100 total because your medications are on a preferred tier. The difference between the cheapest and most expensive plan covering the same drugs can easily exceed $1,000 per year. A Kaiser Family Foundation analysis found that Part D enrollees who actively compared and switched plans saved several hundred dollars annually on average compared to those who stayed in their existing plan without reviewing alternatives.
If your income is limited, the Extra Help program — formally called the Low Income Subsidy — may be the most valuable program you are not using. In 2025, Extra Help is available to individuals with annual incomes below approximately $22,590 (or $30,660 for married couples) and limited assets. Qualifying can reduce your Part D premium to $0, eliminate the late enrollment penalty entirely, and cap your drug copays at $4.50 for generics and $11.20 for brand-name drugs. You apply through the Social Security Administration at ssa.gov or by calling 1-800-772-1213, and you can apply at any time of year — eligibility is not restricted to enrollment periods. If you are already enrolled in Medicaid, Supplemental Security Income, or a Medicare Savings Program, you likely qualify for Extra Help automatically and should already be receiving it. Given the subsidy changes now in motion, this program becomes even more critical as a financial safety net for lower-income beneficiaries.
For people on Original Medicare who carry a Medigap supplemental policy, the drug coverage question is separate. Medigap plans — Plan G, Plan N, and the others — do not cover prescription drugs, so you need a standalone Part D plan alongside your Medigap policy. Medigap premiums are set by the insurer and are not directly affected by Part D subsidy changes, but if you are already paying $150 or more per month for a Medigap policy and your Part D premium rises by $20 or $30, the combined monthly insurance burden grows meaningfully. In that situation, it may be worth using Medicare.gov's Plan Finder to compare whether a Medicare Advantage plan bundling drug coverage could lower your total annual costs — though you would be trading Original Medicare's broad, nationwide provider access for a network-based plan. That trade-off is worth analyzing carefully, not making impulsively, particularly if you have established relationships with specialists who may not be in an MA network.
State Health Insurance Assistance Programs, known as SHIP, offer free, unbiased counseling from trained volunteers who can walk through your specific plan options with you — in person, by phone, or virtually. SHIP counselors do not sell insurance and receive no commission from any plan. They can help you use the Plan Finder, interpret your Annual Notice of Change letter, and identify whether you qualify for Extra Help or a Medicare Savings Program. To find your local SHIP, call 1-800-MEDICARE (1-800-633-4227) or visit shiphelp.org. These counselors are especially valuable when you are managing multiple chronic conditions with expensive medications, because the interaction between formulary tiers, prior authorization rules, and cost-sharing structures can be genuinely complex to navigate alone.
The broader policy context is worth stating plainly. Medicare drug coverage has always been a negotiation between the federal government, private insurers, and pharmaceutical companies. When Washington reduces what it pays insurers, beneficiaries frequently absorb the difference through higher premiums, narrower formularies, or reduced supplemental benefits. That dynamic is not new, but the scale of the current subsidy restructuring is significant enough that health policy analysts across the political spectrum are flagging it as a meaningful cost shift onto seniors. The $2,000 out-of-pocket cap remains in place, which is real and important protection for high-cost drug users. But the monthly premium burden — the cost of simply staying enrolled in a drug plan — may rise for many people who have not seen significant increases in recent years.
Do not wait until mid-October to start preparing. When your Annual Notice of Change letter arrives in late September, read it the same day. Write down every medication you take, the exact dose, and how often you fill it. Use that list on Medicare.gov's Plan Finder to run a real cost comparison across every plan in your zip code. If your income is modest, apply for Extra Help now — you do not have to wait for open enrollment. And if you want a knowledgeable person to help you sort through the options without any sales pressure, call your state SHIP program. The policy changes happening in Washington are real, but so are the tools available to help you respond to them before January 1.